Deprecated: Required parameter $cat_id follows optional parameter $type in /www/wwwroot/ebimall.com/systems/hong.php on line 2088

Deprecated: Required parameter $where follows optional parameter $tree_id in /www/wwwroot/ebimall.com/systems/hlb.php on line 3505
absoluteantibody/Ab00740-10.0 Anti-DR5 [PRO95780 (Drozitumab)]/Ab00740-10.0/ 200 µg188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

absoluteantibody/Ab00740-10.0 Anti-DR5 [PRO95780 (Drozitumab)]/Ab00740-10.0/ 200 µg

Description: Recombinant monoclonal antibody to DR5. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the therapeutic antibody PRO95780 (Drozitumab).
Species and Isotype: Human IgG1, lambda
Clone Number: PRO95780 (Drozitumab)
UniProt Accession Number of Target Protein: O14763
Published Application(s): functional/therapeutic; agonist; IP; immunoblot; ELISA; IF
Published Species Reactivity: Human
Immunogen: The variable domains of this antibody were derived as scFv from a human antibody phage display library, with biotinylated DR5-Fc used to capture DR5-specific phage. The scFv obtained were subsequently reformatted into full-length antibodies.
Specificity: This antibody is specific for human death receptor 5, a proapoptotic receptor widely expressed in adult and fetal tissues, with notably high expression on tumour cells. Activation of DR5 triggers apoptosis in various types of cancer cells, without affecting most normal cell types.
Application Notes: This antibody binds DR5, triggering DR5 clustering and DISC activation in a range of cancer cells, including colorectal cancer and NSCLC cells (Adams, 2009). Conversely, this antibody showed no effector caspase activation or cell death induction in normal human hepatocytes. In vivo, this antibody has been shown to inhibit tumor xenograft growth in a variety of animal models (Varfolomeev, 2009). This antibody was used in IP, immunoblot, ELISA and IF analysis to precisely characterise its interaction with the DR5 ligand (Adams, 2009).
Antibody First Published in:
Adams et al. Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5. Cell Death Differ. 2008 Apr;15(4):751-61 PMID:18219321 Note on publication: Describes the generation of this antibody from a phage display library, and subsequent characterisation of its binding specificity.

Product Form

Purification: Protein A affinity purified
Supplied in: PBS only.
Storage Recommendation: Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C
Concentration: See vial label.

Important note – This product is for research use only. It is not intended for use in therapeutic or diagnostic procedures for humans or animals.
新闻动态
行业前沿
技术文章
最新产品